Ignite Creation Date:
2024-05-06 @ 12:28 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03761914
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-02-21
First Post:
2018-11-28
Brief Title:
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sponsor:
Sellas Life Sciences Group
Organization:
Sellas Life Sciences Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-28
First Submit QC Date:
November 30 2018
Study First Post Date:
2018-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-18
Last Update Post Date:
2022-02-21
Last Update Post Date Type:
ACTUAL